1991
Treatment for Acute Myelocytic Leukemia With Allogeneic Bone Marrow Transplantation Following Preparation With BuCy2
Copelan E, Biggs J, Thompson J, Crilley P, Szer J, Klein J, Kapoor N, Avalos B, Cunningham I, Atkinson K, Downs K, Harmon G, Daly M, Brodsky I, Bulova S, Tutschka P. Treatment for Acute Myelocytic Leukemia With Allogeneic Bone Marrow Transplantation Following Preparation With BuCy2. Blood 1991, 78: 838-843. DOI: 10.1182/blood.v78.3.838.838.Peer-Reviewed Original ResearchLeukemia-free survivalAcute myelocytic leukemiaAllogeneic bone marrow transplantationBone marrow transplantationMarrow transplantationMyelocytic leukemiaActuarial probability of relapseDecreased LFSFrench-American-British classificationBusulfan 4 mg/kgDiagnosis to transplantPrimary refractory diseaseTotal body irradiationProbability of relapseAdvanced disease phaseOne-hundredActuarial probabilityPreparative regimenHLA-identicalRemission patientsBody irradiationPrognostic factorsRefractory diseaseHematological disordersRelapse
1985
Breast Cancer Prognosis in a Mixed Caucasian-Hispanic Population23
Daly M, Clark G, McGuire W. Breast Cancer Prognosis in a Mixed Caucasian-Hispanic Population23. Journal Of The National Cancer Institute 1985, 74: 753-757. PMID: 3857371, DOI: 10.1093/jnci/74.4.753.Peer-Reviewed Original ResearchConceptsHispanic womenYears of ageCaucasian womenIncidence of breast cancerPopulation of Hispanic womenProportion of Hispanic womenER statusLymph nodesEstrogen receptorBreast cancerPositive axillary lymph nodesPositive lymph nodesAxillary lymph nodesExtent of diseaseBreast cancer prognosisPrognostic factorsComplete dataAge groupsMultivariate analysisCancer prognosisWomenBreastCancerAgeStatus